Drug Type Small molecule drug |
Synonyms 3-amino-4-{(3S)-3-[(2-ethoxyethoxy)methyl]piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxamide |
Target |
Mechanism CDK8 inhibitors(Cyclin-dependent kinase 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H26N4O3S |
InChIKeyGOAKYBVMJUXOFY-LBPRGKRZSA-N |
CAS Registry2871872-79-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Preclinical | JP | 01 Dec 2021 | |
Bone Diseases, Metabolic | Discovery | JP | 09 Sep 2021 |